IDEXX Laboratories, Inc. P/E Ratio 2008–2025
IDEXX Laboratories, Inc. reported 51.72 of price-to-earnings ratio for fiscal 2025. That was 33.5% higher than fiscal 2024. Compared with fiscal 2020, the change was -30.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 51.72 | +33.5% |
| FY 2024 | 38.75 | -29.8% |
| FY 2023 | 55.17 | +8.6% |
| FY 2022 | 50.80 | -33.6% |
| FY 2021 | 76.57 | +2.8% |
| FY 2020 | 74.50 | +39.5% |
| FY 2019 | 53.40 | +22.3% |
| FY 2018 | 43.67 | -17.9% |
| FY 2017 | 53.19 | +10.7% |
| FY 2016 | 48.06 | +35.1% |
| FY 2015 | 35.57 | -14.1% |
| FY 2014 | 41.42 | +35.5% |
| FY 2013 | 30.57 | +4.4% |
| FY 2012 | 29.27 | +5.7% |
| FY 2011 | 27.68 | -5.2% |
| FY 2010 | 29.21 | +9.8% |
| FY 2009 | 26.59 | +37.8% |
| FY 2008 | 19.29 | — |
Source: IDEXX Laboratories, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open IDXX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
IDEXX Laboratories, Inc. reported 51.72 of price-to-earnings ratio for fiscal 2025. That was 33.5% higher than fiscal 2024. Compared with fiscal 2020, the change was -30.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for IDEXX Laboratories, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIDEXX Laboratories, Inc. — frequently asked questions
What is IDEXX Laboratories, Inc.'s price-to-earnings ratio?
IDEXX Laboratories, Inc. (IDXX) reported price-to-earnings ratio of 51.72 for fiscal year 2025, per its SEC filings.
How has IDEXX Laboratories, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, IDXX's price-to-earnings ratio grew at roughly 6.0% per year (compound annual rate), from 19.29 to 51.72.
Where does this data come from?
Figures are computed from IDEXX Laboratories, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More IDXX financial history
Full IDXX fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →